Delivery Order SPE2DB22D3102-SPE2DB25FL2FH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,020.48 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 4% Solution in 50ml units. This firm fixed-price delivery order, awarded on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,376.18 to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 mL vials (5 mL quantity). The award is firm fixed price with no set-aside designation, reflecting a competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate office location. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,903.04 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Lidocaine HCL 1% 50 mg/5 ml vials (5 ml). This firm fixed-price delivery order, which represents a non-set-aside competitive award, is scheduled for completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania. The contract leverages AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,437.99 to AmerisourceBergen Drug Corp for Lidocaine HCL 1% vials (10 mL) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract utilizes firm fixed pricing with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Lidocaine HCL 50ML in quantities of 25 units, with a contract value of $1,360.90. This is a firm fixed-price delivery order with no set-aside designation, meaning the award was made through open competition. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August...
- The Defense Logistics Agency awarded a $2,030.80 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Lidocaine 2% Viscous in 15 ML cup unit dose format. This non-set-aside, firm fixed price contract is scheduled for completion by July 30, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Department, through its Medical Supply Chain division, awarded a delivery order valued at $1,712.10 to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Lidocaine HCL in 50ML quantities (25 units). The contract employs firm fixed pricing with no set-aside designation, indicating competitive award based on open competition. Performance will be executed at the contractor's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order valued at $8,087.53 to AmerisourceBergen Drug Corp for the supply of Lidocaine HCL 2% 200 mg/10 mL vials. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) awarded Delivery Order SPE2DB24FXXW9 to Amerisourcebergen Drug Corp, Corporate Office Division, with a ceiling value of $1,378.15. This firm-fixed price contract is for the supply of 4,564,558,341 units of Lidocaine HCL 4% Solution 4ML. The contract has an ultimate completion date of May 10, 2024. This delivery order is issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract worth $3,889.21 to Amerisourcebergen Drug Corp, a wholly owned subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the supply of 4564133886 - Lidocaine 2% Viscous Solution 100ML, with a period of performance through April 2, 2024. This delivery order is issued under a single-award indefinite delivery contract (IDC) held...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2FHDelivery Order
The Defense Logistics Agency awarded a $1,387.67 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Lidocaine 0.8% in D5W Solution in 250ml units. The delivery order, with an ultimate completion date of July 25, 2025, represents a single-day fulfillment requirement for this pharmaceutical product. This award was made without a set-aside designation, indicating it was competitively awarded through open procurement processes. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a $999,999,999.00 potential value through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to military healthcare programs worldwide. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen's contract portfolio with DLA demonstrates its capability to deliver diverse pharmaceutical commodities ranging from specialty medications to generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/24/25 |